Drugs / DEH113
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT06268054 | Feb 2025 → Feb 2027 expected | primary dysmenorrhea | EMS | Not yet recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06555549 | Sep 2024 → Sep 2025 overdue | primary dysmenorrhea | EMS | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DEH113 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06555549 ↗ |